We use essential and non-essential cookies. By using our website, you agree to our use of cookies as described in Cookie Policy.
Cookie policy →
Latin America: How patents and licensing hinder access to COVID-19 treatments- Baricitnib patent landscape
Latin America: How patents and licensing hinder access to COVID-19 treatments- patent status
Latin America: How patents and licensing hinder access to COVID-19 treatments- Pfizer
Latin America: How patents and licensing hinder access to COVID-19 treatments- Eli Lilly
Latin America: How patents and licensing hinder access to COVID-19 treatments- Pfizer LATAM Map
Latin America: How patents and licensing hinder access to COVID-19 treatments- Patent status
Latin America: How patents and licensing hinder access to COVID-19 treatments- price comparisons
2022
TRIPS - IP - Mar 2022
Cepheid COVID-19 test price reduction - 01.07.2021
COVID-19 Access Campaign Material
The People Facing the Pandemic - 10.9.2021
Video
Quote graphics editable files
World Health Assembly 73 Assets
Editable files
Quote graphics
00 - Quotes
10 - Assets
30 - Social Media Plan
COVID-19 Vaccine - Access - No Petition
Graphics
Editable Files
People's Vaccine - COVID-19 - Pharma CEO letter - Jan 2021
Editable
Vax listicle update - 26.4.2021
Squared Images